Search

Author/Creator Chuang, Jen‐Chieh

2. Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH. Issue 2 (15th February 2021)

Authors:
Loomba, Rohit; Noureddin, Mazen; Kowdley, Kris V.; Kohli, Anita; Sheikh, Aasim; Neff, Guy; Bhandari, Bal Raj; Gunn, Nadege; Caldwell, Stephen H.; Goodman, Zachary; Wapinski, Ilan; Resnick, Murray; Beck, Andrew H.; Ding, Dora; Jia, Catherine; Chuang, Jen‐Chieh; Huss, Ryan S.; Chung, Chuhan; Subram...
Journal:
Hepatology
Issue:
Volume 73:Issue 2(2021)
Page Start:
625
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH. Issue 1 (17th January 2023)

Authors:
Xu, Jun; Wang, Ya; Khoshdeli, Mina; Peach, Matt; Chuang, Jen‐Chieh; Lin, Julie; Tsai, Wen‐Wei; Mahadevan, Sangeetha; Minto, Wesley; Diehl, Lauri; Gupta, Ruchi; Trauner, Michael; Patel, Keyur; Noureddin, Mazen; Kowdley, Kris V.; Gulamhusein, Aliya; Bowlus, Christopher L.; Huss, Ryan S.; Myers, Rob...
Journal:
Hepatology
Issue:
Volume 77:Issue 1(2023)
Page Start:
20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD. Issue 6 (23rd June 2022)

Authors:
Smirnova, Ekaterina; Muthiah, Mark D.; Narayan, Nicole; Siddiqui, Mohamad S.; Puri, Puneet; Luketic, Velimir A.; Contos, Melissa J.; Idowu, Michael; Chuang, Jen‐Chieh; Billin, Andrew N.; Huss, Ryan S.; Myers, Robert P.; Boyett, Sherry; Seneshaw, Mulugeta; Min, Hae‐Ki; Mirshahi, Faridodin; Sanyal,...
Journal:
Hepatology
Issue:
Volume 76:Issue 6(2022)
Page Start:
1811
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. Issue 3 (10th March 2019)

Authors:
Trauner, Michael; Gulamhusein, Aliya; Hameed, Bilal; Caldwell, Stephen; Shiffman, Mitchell L.; Landis, Charles; Eksteen, Bertus; Agarwal, Kosh; Muir, Andrew; Rushbrook, Simon; Lu, Xiaomin; Xu, Jun; Chuang, Jen‐Chieh; Billin, Andrew N.; Li, Georgia; Chung, Chuhan; Subramanian, G. Mani; Myers, Robe...
Journal:
Hepatology
Issue:
Volume 70:Issue 3(2019)
Page Start:
788
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗